News & events
News
The discovery of a new critical enzyme could help engineer climate resilient crops capable of sucking far more carbon dioxide from the atmosphere in a much more efficient way.
Professor Alexander Maier wants us to change our mind about parasites.
Meet the PhD researcher exploring how bacterial proteins could hold the key to reducing our reliance on fossil fuels.
Researchers have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global fight against the disease.
A low-cost, non-toxic cancer treatment has been developed by researchers at The Australian National University (ANU). The treatment uses dead bacteria to help kick-start the immune system and shrink cancer.
Researchers from The Australian National University (ANU) have exposed a fatal flaw in the deadly parasite that causes malaria - one of the world's biggest killers.
Events
Immunotherapy is a re-emerging alternative to other invasive and debilitating cancer treatments. Monoclonal antibodies that disrupt immune checkpoint molecules, such as PD1 or CTLA4, continually demonstrate great promise.
Membrane transport proteins, also known as transporters, are crucial for the maintenance of cell physiology by facilitating the movement of ions, nutrients, metabolites, and waste across cell membranes.
F1Fo ATP synthase generates the majority of cellular energy by interconverting phosphate transfer energy and proton motive force via a rotary catalytic mechanism. Using cryo electron microscopy we have provided molecular snapshots of this complex enzyme in multiple states.
The Acinetobacter genus includes at least 70 named species that occupy environments which differ broadly in nutrient composition, water availability, temperature and other abiotic characteristics.
Malaria remains the deadliest parasitic disease in the world despite years of sustained effort, new drug development, and a greater understanding of the causative parasite, Plasmodium, and its interactions with its host.
Malaria kills around 400,000 people each year and the prevention and treatment of this disease is highly reliant on chemotherapy.